250 related articles for article (PubMed ID: 21044322)
1. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
[TBL] [Abstract][Full Text] [Related]
2. A broad analysis in clinical and in vitro models on regulator of G-protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance.
Kucuk B; Kibar B; Cacan E
Cell Biochem Funct; 2021 Apr; 39(3):413-422. PubMed ID: 33354811
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G-protein signalling expression and function in ovarian cancer cell lines.
Hurst JH; Mendpara N; Hooks SB
Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
[TBL] [Abstract][Full Text] [Related]
5. Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.
Hooks SB; Murph MM
Future Med Chem; 2015 Aug; 7(12):1483-9. PubMed ID: 26293348
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Ali MW; Cacan E; Liu Y; Pierce JY; Creasman WT; Murph MM; Govindarajan R; Eblen ST; Greer SF; Hooks SB
PLoS One; 2013; 8(3):e60185. PubMed ID: 23533674
[TBL] [Abstract][Full Text] [Related]
7. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
8. RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.
Alqinyah M; Almutairi F; Wendimu MY; Hooks SB
Mol Pharmacol; 2018 Oct; 94(4):1103-1113. PubMed ID: 30049816
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Altman MK; Alshamrani AA; Jia W; Nguyen HT; Fambrough JM; Tran SK; Patel MB; Hoseinzadeh P; Beedle AM; Murph MM
Cancer Lett; 2015 Dec; 369(1):175-83. PubMed ID: 26319900
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
Cacan E
J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
[TBL] [Abstract][Full Text] [Related]
12. RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma.
Caldiran FY; Cacan E
Pathol Res Pract; 2022 Aug; 236():154007. PubMed ID: 35810565
[TBL] [Abstract][Full Text] [Related]
13. Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Hu Y; Zheng M; Wang S; Gao L; Gou R; Liu O; Dong H; Li X; Lin B
Genomics; 2021 Jul; 113(4):2134-2144. PubMed ID: 33845140
[TBL] [Abstract][Full Text] [Related]
14. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
15. Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.
Hayes MP; Roman DL
AAPS J; 2016 May; 18(3):550-9. PubMed ID: 26928451
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
Park J; Park SY; Kim JH
Biochim Biophys Acta; 2016 Feb; 1863(2):236-43. PubMed ID: 26597704
[TBL] [Abstract][Full Text] [Related]
17. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2.
Cui Y; Qin L; Tian D; Wang T; Fan L; Zhang P; Wang Z
Chemotherapy; 2018; 63(5):262-271. PubMed ID: 30481785
[TBL] [Abstract][Full Text] [Related]
18. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity.
Alqinyah M; Maganti N; Ali MW; Yadav R; Gao M; Cacan E; Weng HR; Greer SF; Hooks SB
Mol Pharmacol; 2017 Mar; 91(3):197-207. PubMed ID: 28031332
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9.
Jia W; Eneh JO; Ratnaparkhe S; Altman MK; Murph MM
Mol Cancer Res; 2011 Dec; 9(12):1732-45. PubMed ID: 22024689
[TBL] [Abstract][Full Text] [Related]
20. Smoothened antagonists reverse taxane resistance in ovarian cancer.
Steg AD; Katre AA; Bevis KS; Ziebarth A; Dobbin ZC; Shah MM; Alvarez RD; Landen CN
Mol Cancer Ther; 2012 Jul; 11(7):1587-97. PubMed ID: 22553355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
